These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 17441911)
1. The natural history of untreated renal masses. Crispen PL; Uzzo RG BJU Int; 2007 May; 99(5 Pt B):1203-7. PubMed ID: 17441911 [No Abstract] [Full Text] [Related]
2. Editorial comment on: Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. Novara G Eur Urol; 2009 May; 55(5):1153-4. PubMed ID: 18930580 [No Abstract] [Full Text] [Related]
3. Prognostic factors in renal cell cancer. Park WH; Eisen T BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924 [No Abstract] [Full Text] [Related]
5. Observation should be considered as an alternative in management of renal masses in older and comorbid patients. Beisland C; Hjelle KM; Reisaeter LA; Bostad L Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267 [TBL] [Abstract][Full Text] [Related]
6. Editorial comment on: Observation should be considered as an alternative in management of renal masses in older and comorbid patients. Remzi M Eur Urol; 2009 Jun; 55(6):1427-8. PubMed ID: 19147268 [No Abstract] [Full Text] [Related]
7. Editorial comment on: Observation should be considered as an alternative in management of renal masses in older and comorbid patients. Volpe A Eur Urol; 2009 Jun; 55(6):1428-9. PubMed ID: 19147272 [No Abstract] [Full Text] [Related]
10. The survival of patients with bone metastases from renal cell carcinoma. Maffezzini M Eur Urol; 2007 Jul; 52(1):169. PubMed ID: 17616084 [No Abstract] [Full Text] [Related]
11. Temsirolimus in patients with renal cancer on hemodialysis. Lunardi G; Vannozzi MO; Armirotti A; Nicodemo M; Venturini M; Cavallini L J Clin Oncol; 2008 Dec; 26(34):5652-3; author reply 5653-4. PubMed ID: 18981458 [No Abstract] [Full Text] [Related]
14. Renal tumor natural history: the rationale and role for active surveillance. Jewett MA; Zuniga A Urol Clin North Am; 2008 Nov; 35(4):627-34; vii. PubMed ID: 18992616 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cells for the treatment of metastatic renal cell carcinoma: at a low ebb? Patard JJ Eur Urol; 2006 Jul; 50(1):11-3. PubMed ID: 16713068 [No Abstract] [Full Text] [Related]
16. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Marshall FM J Urol; 2005 Sep; 174(3):868-9. PubMed ID: 16093973 [No Abstract] [Full Text] [Related]